brook house pharma limited

2

brook house pharma limited Company Information

Share BROOK HOUSE PHARMA LIMITED
Live 
YoungMicroDeclining

Company Number

11341417

Website

-

Registered Address

8 beehive lane, ilford, IG1 3RD

Industry

Dispensing chemist in specialised stores

 

Telephone

-

Next Accounts Due

December 2024

Group Structure

View All

Directors

Ariel Oberlander5 Years

Suzanne Oberlander5 Years

Shareholders

ariel oberlander 52%

suzanne oberlander 48%

brook house pharma limited Estimated Valuation

£18.8k

Pomanda estimates the enterprise value of BROOK HOUSE PHARMA LIMITED at £18.8k based on a Turnover of £100.5k and 0.19x industry multiple (adjusted for size and gross margin).

brook house pharma limited Estimated Valuation

£39.1k

Pomanda estimates the enterprise value of BROOK HOUSE PHARMA LIMITED at £39.1k based on an EBITDA of £21.1k and a 1.85x industry multiple (adjusted for size and gross margin).

brook house pharma limited Estimated Valuation

£0

Pomanda estimates the enterprise value of BROOK HOUSE PHARMA LIMITED at £0 based on Net Assets of £-39.8k and 2.03x industry multiple (adjusted for liquidity).

Valuation Calculator
This valuation is estimated based on financial data from March 2023 

Brook House Pharma Limited AI Business Plan

In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.

View Sample

Brook House Pharma Limited Overview

Brook House Pharma Limited is a live company located in ilford, IG1 3RD with a Companies House number of 11341417. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in May 2018, it's largest shareholder is ariel oberlander with a 52% stake. Brook House Pharma Limited is a young, micro sized company, Pomanda has estimated its turnover at £100.5k with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Brook House Pharma Limited Health Check

Pomanda's financial health check has awarded Brook House Pharma Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 6 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating2out of 5
positive_score

1 Strong

positive_score

3 Regular

positive_score

6 Weak

size

Size

annual sales of £100.5k, make it smaller than the average company (£12.1m)

£100.5k - Brook House Pharma Limited

£12.1m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -60%, show it is growing at a slower rate (5.2%)

-60% - Brook House Pharma Limited

5.2% - Industry AVG

production

Production

with a gross margin of 26.3%, this company has a comparable cost of product (31.4%)

26.3% - Brook House Pharma Limited

31.4% - Industry AVG

profitability

Profitability

an operating margin of 21% make it more profitable than the average company (3.5%)

21% - Brook House Pharma Limited

3.5% - Industry AVG

employees

Employees

with 1 employees, this is below the industry average (84)

1 - Brook House Pharma Limited

84 - Industry AVG

paystructure

Pay Structure

on an average salary of £22k, the company has an equivalent pay structure (£22k)

£22k - Brook House Pharma Limited

£22k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £100.5k, this is less efficient (£139.2k)

£100.5k - Brook House Pharma Limited

£139.2k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 51 days, this is later than average (30 days)

51 days - Brook House Pharma Limited

30 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 64 days, this is close to average (67 days)

64 days - Brook House Pharma Limited

67 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Brook House Pharma Limited

- - Industry AVG

cashbalance

Cash Balance

There is insufficient data available for this Key Performance Indicator!

- - Brook House Pharma Limited

- - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 381.7%, this is a higher level of debt than the average (61%)

381.7% - Brook House Pharma Limited

61% - Industry AVG

brook house pharma limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for brook house pharma limited. Get real-time insights into brook house pharma limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Brook House Pharma Limited Competitor Analysis

BETA
competitor_analysis_table_img

Perform a competitor analysis for brook house pharma limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

brook house pharma limited Ownership

BROOK HOUSE PHARMA LIMITED group structure

Brook House Pharma Limited has no subsidiary companies.

Ultimate parent company

BROOK HOUSE PHARMA LIMITED

11341417

BROOK HOUSE PHARMA LIMITED Shareholders

ariel oberlander 52%
suzanne oberlander 48%

brook house pharma limited directors

Brook House Pharma Limited currently has 2 directors. The longest serving directors include Mr Ariel Oberlander (May 2018) and Mrs Suzanne Oberlander (May 2018).

officercountryagestartendrole
Mr Ariel OberlanderEngland59 years May 2018- Director
Mrs Suzanne OberlanderEngland62 years May 2018- Director

BROOK HOUSE PHARMA LIMITED financials

EXPORTms excel logo

Brook House Pharma Limited's latest turnover from March 2023 is estimated at £100.5 thousand and the company has net assets of -£39.8 thousand. According to their latest financial statements, Brook House Pharma Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Turnover100,510497,1001,498,8121,528,6981,581,639
Other Income Or Grants00000
Cost Of Sales74,096360,4921,128,9561,152,2041,186,762
Gross Profit26,414136,608369,856376,495394,877
Admin Expenses5,303124,713375,542384,125448,102
Operating Profit21,11111,895-5,686-7,630-53,225
Interest Payable00000
Interest Receivable00000
Pre-Tax Profit21,11111,895-5,686-7,630-53,225
Tax-4,011-2,260000
Profit After Tax17,1009,635-5,686-7,630-53,225
Dividends Paid00000
Retained Profit17,1009,635-5,686-7,630-53,225
Employee Costs21,95741,11277,51156,78473,985
Number Of Employees12434
EBITDA*21,11111,895-5,686-7,630-53,225

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Tangible Assets00405,895430,523455,351
Intangible Assets00000
Investments & Other00000
Debtors (Due After 1 year)00000
Total Fixed Assets00405,895430,523455,351
Stock & work in progress00000
Trade Debtors14,132112,468458,431471,017464,742
Group Debtors00000
Misc Debtors00000
Cash00000
misc current assets00000
total current assets14,132112,468458,431471,017464,742
total assets14,132112,468864,326901,540920,093
Bank overdraft00000
Bank loan00000
Trade Creditors 13,152125,483317,274317,041312,612
Group/Directors Accounts00000
other short term finances00000
hp & lease commitments00000
other current liabilities00000
total current liabilities13,152125,483317,274317,041312,612
loans00000
hp & lease commitments00000
Accruals and Deferred Income00000
other liabilities40,78643,891613,593645,354660,706
provisions00000
total long term liabilities40,78643,891613,593645,354660,706
total liabilities53,938169,374930,867962,395973,318
net assets-39,806-56,906-66,541-60,855-53,225
total shareholders funds-39,806-56,906-66,541-60,855-53,225
Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Operating Activities
Operating Profit21,11111,895-5,686-7,630-53,225
Depreciation00000
Amortisation00000
Tax-4,011-2,260000
Stock00000
Debtors-98,336-345,963-12,5866,275464,742
Creditors-112,331-191,7912334,429312,612
Accruals and Deferred Income00000
Deferred Taxes & Provisions00000
Cash flow from operations3,105163,8077,133-9,476-205,355
Investing Activities
capital expenditure0405,89524,62824,828-455,351
Change in Investments00000
cash flow from investments0405,89524,62824,828-455,351
Financing Activities
Bank loans00000
Group/Directors Accounts00000
Other Short Term Loans 00000
Long term loans00000
Hire Purchase and Lease Commitments00000
other long term liabilities-3,105-569,702-31,761-15,352660,706
share issue00000
interest00000
cash flow from financing-3,105-569,702-31,761-15,352660,706
cash and cash equivalents
cash00000
overdraft00000
change in cash00000

P&L

March 2023

turnover

100.5k

-80%

operating profit

21.1k

0%

gross margin

26.3%

-4.37%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2023

net assets

-39.8k

-0.3%

total assets

14.1k

-0.87%

cash

0

0%

net assets

Total assets minus all liabilities

brook house pharma limited company details

company number

11341417

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

incorporation date

May 2018

age

6

accounts

Micro-Entity Accounts

ultimate parent company

None

previous names

N/A

incorporated

UK

address

8 beehive lane, ilford, IG1 3RD

last accounts submitted

March 2023

brook house pharma limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 1 charges/mortgages relating to brook house pharma limited. Currently there are 0 open charges and 1 have been satisfied in the past.

charges

brook house pharma limited Companies House Filings - See Documents

datedescriptionview/download